ArticleFrontiers in pharmacology2024

Case Report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression.

Hejing Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.